Related references
Note: Only part of the references are listed.Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
Impact of intravenous and subcutaneous immunoglobulins on false positivity of galactomannan and β-D-glucan antigenaemia and detection of circulating Aspergillus fumigatus DNA
M. -E. Bougnoux et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis
Antonios Kritikos et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Comparison of β-D-Glucan and Galactomannan in Serum for Detection of Invasive Aspergillosis: Retrospective Analysis with Focus on Early Diagnosis
Karl Dichtl et al.
JOURNAL OF FUNGI (2020)
Diagnostic Accuracy of -d-Glucan (Fungitell) Testing Among Patients With Hematologic Malignancies or Solid Organ Tumors: A Systematic Review and Meta-Analysis
Sandra K. White et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies
Li Zhang et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Performance of 1,3-beta-D-glucan in the diagnosis and monitoring of invasive fusariosis
Marcio Nucci et al.
MYCOSES (2019)
Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study
T. Boch et al.
JOURNAL OF CRITICAL CARE (2018)
Usefulness of ss-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients
J. Guitard et al.
JOURNAL OF INFECTION (2018)
Diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies
Lu Xiaoling et al.
OPEN MEDICINE (2018)
Detection of (1,3)-β-D-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients
Eric Levesque et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units
Daniele Roberto Giacobbe et al.
CRITICAL CARE (2017)
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study
Brunella Posteraro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-D-glucan
Marcio Nucci et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Comparison of 1,3-β-D-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients
Tobias Lahmer et al.
JOURNAL OF CRITICAL CARE (2016)
Diagnostic value of (1 → 3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis
Xin-yu Shi et al.
RESPIRATORY MEDICINE (2016)
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis
Estrella Martin-Mazuelos et al.
INTENSIVE CARE MEDICINE (2015)
Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment
M. Carmen Martinez-Jimenez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Candida biomarkers in patients with candidaemia and bacteraemia
M. Carmen Martinez-Jimenez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-beta-D-glucan for invasive fungal infection: Focus on cutoff levels
Song He et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Bronchoalveolar Lavage Fluid (1,3)β-D-Glucan for the Diagnosis of Invasive Fungal Infections in Solid Organ Transplantation: A Prospective Multicenter Study
Wolfgang Mutschlechner et al.
TRANSPLANTATION (2015)
Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients
Nina Singh et al.
TRANSPLANTATION (2015)
Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit
G. Lo Cascio et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Contribution of (1,3)-Beta-D-Glucan to Diagnosis of Invasive Candidiasis after Liver Transplantation
E. Levesque et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature
Juergen Prattes et al.
MYCOSES (2015)
The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort Studies
Tie-Ying Hou et al.
PLOS ONE (2015)
Utility of (1-3)-β-D-Glucan Testing for Diagnostics and Monitoring Response to Treatment During the Multistate Outbreak of Fungal Meningitis and Other Infections
Anastasia P. Litvintseva et al.
CLINICAL INFECTIOUS DISEASES (2014)
MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting
Luis Ostrosky-Zeichner et al.
CLINICAL INFECTIOUS DISEASES (2014)
Nonmolecular Methods for the Diagnosis of Respiratory Fungal Infections
Frederic Lamoth et al.
CLINICS IN LABORATORY MEDICINE (2014)
Diagnostic Value of the Serum Galactomannan and (1,3)-β-D-glucan Assays for Invasive Pulmonary Aspergillosis in Non-neutropenic Patients
Xuejiu Cai et al.
INTERNAL MEDICINE (2014)
Serum 1,3-beta-D-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery
Juergen Prattes et al.
MYCOSES (2014)
Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation
Julien Poissy et al.
CRITICAL CARE (2014)
β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture-Negative Intraabdominal Candidiasis
Frederic Tissot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Accuracy of beta-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis
D. E. Karageorgopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Cerebrospinal Fluid (1,3)-β-D-Glucan Detection as an Aid for Diagnosis of Iatrogenic Fungal Meningitis
Jennifer L. Lyons et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
O. Marchetti et al.
BONE MARROW TRANSPLANTATION (2012)
β-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)
Frederic Lamoth et al.
CLINICAL INFECTIOUS DISEASES (2012)
(1,3)-β-D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Siraya Jaijakul et al.
CLINICAL INFECTIOUS DISEASES (2012)
Post-diagnostic kinetics of the (1→3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia
S. Koo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease
J. Acosta et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions
Cristobal Leon et al.
INTENSIVE CARE MEDICINE (2012)
Is elevation of the serum β-D-glucan level a paradoxical sign for Trichosporon fungemia in patients with hematologic disorders?
Kazunori Nakase et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Diagnostic Accuracy of Serum 1,3-beta-D-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis
Akira Onishi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis
Charles R. Sims et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
Kimberly E. Hanson et al.
PLOS ONE (2012)
β-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Drosos E. Karageorgopoulos et al.
CLINICAL INFECTIOUS DISEASES (2011)
A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-β-D-glucan chromogenic assay in serum samples
J. Acosta et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Diagnosis of Invasive Fungal Disease Using Serum (1 -> 3)-beta-D-Glucan: A Bivariate Meta-Analysis
Yuan Lu et al.
INTERNAL MEDICINE (2011)
Prospective Survey of (1 -> 3)-beta-D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting
John F. Mohr et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Beta-D-Glucan Detection as a Diagnostic Test for Invasive Aspergillosis in Immunocompromised Critically Ill Patients with Symptoms of Respiratory Infection: an Autopsy-Based Study
Greet De Vlieger et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1 -> 3)-beta-D-glucan assay, Candida score, and colonization index
Brunella Posteraro et al.
CRITICAL CARE (2011)
Fatal Trichosporon fungemia in patients with hematologic malignancies
Kei Suzuki et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
The (1,3)β-D-Glucan Test as an Aid to Early Diagnosis of Invasive Fungal Infections following Lung Transplantation
Barbara D. Alexander et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Difficulties in using 1,3-β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis
Zdenek Racil et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Detection of (1→3)-β-D-Glucan as an Adjunct to Diagnosis in a Mixed Population with Uncommon Proven Invasive Fungal Diseases or with an Unusual Clinical Presentation
Maria Soledad Cuetara et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Diagnostic Performance of the (1→3)-β-D-Glucan Assay for Invasive Fungal Disease
Sophia Koo et al.
CLINICAL INFECTIOUS DISEASES (2009)
Usefulness of the Candida score for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
Cristobal Leon et al.
CRITICAL CARE MEDICINE (2009)
Invasive fungal infections and (1,3)-β-D-glucan serum concentrations in long-term intensive care patients
Elisabeth Presterl et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
Utility of Galactomannan Enzyme Immunoassay and (1,3) beta-D-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients
R. Y. Hachem et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia
Laurence Senn et al.
CLINICAL INFECTIOUS DISEASES (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Preemptive treatment of fungal infection based on plasma (1 → 3)β-D-glucan levels after liver transplantation
N. Akamatsu et al.
INFECTION (2007)
Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans
L Ostrosky-Zeichner et al.
CLINICAL INFECTIOUS DISEASES (2005)
Contribution of (1 -> 3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan
C Pazos et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome
Z Odabasi et al.
CLINICAL INFECTIOUS DISEASES (2004)
Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked Immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders
M Kawazu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Share Paper
